Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc.

NASDAQ:FHTX

Overview | Financials
Company Name Foghorn Therapeutics Inc.
Symbol FHTX
Currency USD
Price 9.67
Market Cap 535,028,529
Dividend Yield 0%
52-week-range 2.7 - 10.25
Industry Biotechnology
Sector Healthcare
CEO Mr. Adrian H. B. Gottschalk
Website https://foghorntx.com

An error occurred while fetching data.

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic

Related Stocks

Castle Biosciences, Inc. logo

Castle Biosciences, Inc.

CSTL

30.53 USD

Sangamo Therapeutics, Inc. logo

Sangamo Therapeutics, Inc.

SGMO

0.9 USD

The Pennant Group, Inc. logo

The Pennant Group, Inc.

PNTG

35.61 USD

Bioventus Inc. logo

Bioventus Inc.

BVS

11.59 USD

Surmodics, Inc. logo

Surmodics, Inc.

SRDX

39.4 USD

Financials

Numbers are in millions USD

Numbers are in millions USD